LongBio Pharma (Suzhou) Co., Ltd. (HKG:1779)
Hong Kong · Delayed Price · Currency is HKD 89.85
-5.20 (-5.47%)
Jul 9, 2026, 4:08 PM HKT
LongBio Pharma (Suzhou) Market Cap
LongBio Pharma (Suzhou) has a market cap or net worth of 6.67 billion as of July 9, 2026.
Market Cap
6.67B
Enterprise Value
6.50B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
89.85
Market Cap Chart
Since June 5, 2026, LongBio Pharma (Suzhou)'s market cap has decreased from 9.78B to 6.67B, a decrease of -31.83%. That is a compound annual growth rate of -98.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 6.67B | -5.47% |
| Jul 8, 2026 | 7.05B | -12.07% |
| Jul 7, 2026 | 8.02B | 0.65% |
| Jul 6, 2026 | 7.97B | 1.23% |
| Jul 3, 2026 | 7.87B | 0.19% |
| Jul 2, 2026 | 7.86B | -29.82% |
| Jun 30, 2026 | 11.20B | -0.07% |
| Jun 29, 2026 | 11.20B | 0.67% |
| Jun 26, 2026 | 11.13B | -4.58% |
| Jun 25, 2026 | 11.66B | 3.63% |
| Jun 24, 2026 | 11.26B | -1.49% |
| Jun 23, 2026 | 11.43B | -0.19% |
| Jun 22, 2026 | 11.45B | 8.05% |
| Jun 18, 2026 | 10.59B | 2.00% |
| Jun 17, 2026 | 10.39B | -1.62% |
| Jun 16, 2026 | 10.56B | -0.35% |
| Jun 15, 2026 | 10.59B | -0.76% |
| Jun 12, 2026 | 10.68B | 1.41% |
| Jun 11, 2026 | 10.53B | 3.20% |
| Jun 10, 2026 | 10.20B | -1.65% |
| Jun 9, 2026 | 10.37B | 12.74% |
| Jun 8, 2026 | 9.20B | -5.92% |
| Jun 5, 2026 | 9.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanjing Leads Biolabs | 9.63B |
| Everest Medicines | 9.45B |
| CARsgen Therapeutics Holdings | 8.66B |
| Suzhou Ribo Life Science | 8.28B |
| CStone Pharmaceuticals | 8.21B |
| Abbisko Cayman | 7.69B |
| Lepu Biopharma | 7.54B |
| Shanghai Haohai Biological Technology | 7.26B |